Representative Director Yamagishi speaks at the 5th study session of the “Study Group on Impact Investment Phase 2” co-hosted by the Financial Services Agency and the GSG Domestic Advisory Committee.
President Yamagishi has been appointed as a member of the Impact IPO Working Group of the GSG Domestic Advisory Committee
President Yamagishi has been appointed as Managing Director of the Japan Venture Capital Association (JVCA) and Chairman of the Industry-Academia Collaboration Committee.
Notice of Additional Investment in Photoruction
Notice of Additional Investment in Grace Imaging
Notice of Additional Investment in Heartseed
Notice of Additional Investment in Metagen Therapeutics
Notice of Establishment of ESG Policy
Notice of Additional Investment in iXgene
Notice of New Investment in Hedgehog Medtec, Inc.
Signing of the “Impact-Oriented Finance Declaration
Notice of New Investment in AYUMI BIONICS
Notice of Additional Investment in Metagen Therapeutics
Notice of New Investment in Feliqs
Notice of New Investment in Cloverna
Notice of Additional Investment in Vetanic
Notice of Investment in MAZIN
Notice of Additional Investment in LIFESCAPES
Notice of Investment in Euphoria
Notice of Investment in K Pharma
Notice of Investment in EXORPHIA
App developed by CureApp Received world’s first regulatory approval
Notice of Investment in FingerVision